{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:36:33Z","timestamp":1768008993907,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32122041"],"award-info":[{"award-number":["32122041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100968"],"award-info":[{"award-number":["32100968"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M691809"],"award-info":[{"award-number":["2021M691809"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08405-0","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T12:20:57Z","timestamp":1752668457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular mechanism of human \u03b11A-adrenoceptor inhibition by Mamba snake toxin AdTx1"],"prefix":"10.1038","volume":"8","author":[{"given":"Mingyu","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3162-441X","authenticated-orcid":false,"given":"Angqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2245-4666","authenticated-orcid":false,"given":"Yosuke","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8788-722X","authenticated-orcid":false,"given":"Fang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9375-9742","authenticated-orcid":false,"given":"Xinyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9338-8048","authenticated-orcid":false,"given":"Chuangye","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3178-9238","authenticated-orcid":false,"given":"Xiangyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"8405_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.2174\/1389450120666181105152439","volume":"20","author":"S Saikia","year":"2019","unstructured":"Saikia, S., Bordoloi, M. & Sarmah, R. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection. Curr. Drug Targets 20, 522\u2013539 (2019).","journal-title":"Curr. Drug Targets"},{"key":"8405_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.toxicon.2010.07.010","volume":"56","author":"R Kini","year":"2010","unstructured":"Kini, R. & Doley, R. Structure, function and evolution of three-finger toxins: mini proteins with multiple targets. Toxicon 56, 855\u2013867 (2010).","journal-title":"Toxicon"},{"key":"8405_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4331\/wjbc.v6.i2.28","volume":"6","author":"YN Utkin","year":"2015","unstructured":"Utkin, Y. N. Animal venom studies: current benefits and future developments. World J. Biol. Chem. 6, 28 (2015).","journal-title":"World J. Biol. Chem."},{"key":"8405_CR4","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.peptides.2004.04.006","volume":"25","author":"D Ianzer","year":"2004","unstructured":"Ianzer, D. et al. Identification of five new bradykinin potentiating peptides (BPPs) from Bothrops jararaca crude venom by using electrospray ionization tandem mass spectrometry after a two-step liquid chromatography. Peptides 25, 1085\u20131092 (2004).","journal-title":"Peptides"},{"key":"8405_CR5","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.3390\/molecules26082223","volume":"26","author":"J Frangieh","year":"2021","unstructured":"Frangieh, J. et al. Snake venom components: tools and cures to target cardiovascular diseases. Molecules 26, 2223 (2021).","journal-title":"Molecules"},{"key":"8405_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2174\/1381612053381765","volume":"11","author":"C Marcinkiewicz","year":"2005","unstructured":"Marcinkiewicz, C. Functional characteristic of snake venom disintegrins: potential therapeutic implication. Curr. Pharm. Des. 11, 815\u2013827 (2005).","journal-title":"Curr. Pharm. Des."},{"key":"8405_CR7","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1517\/14656566.3.8.1199","volume":"3","author":"JE Tcheng","year":"2002","unstructured":"Tcheng, J. E. & O\u2019Shea, J. C. Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb\/IIIa. Expert Opin. Pharmacother. 3, 1199\u20131210 (2002).","journal-title":"Expert Opin. Pharmacother."},{"key":"8405_CR8","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1185\/030079902125000237","volume":"18","author":"DG Sherman","year":"2002","unstructured":"Sherman, D. G. Ancrod. Curr. Med. Res. Opin. 18, S48 (2002).","journal-title":"Curr. Med. Res. Opin."},{"key":"8405_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuropharm.2015.01.001","volume":"93","author":"S Hannan","year":"2015","unstructured":"Hannan, S., Mortensen, M. & Smart, T. G. Snake neurotoxin \u03b1-bungarotoxin is an antagonist at native GABAA receptors. Neuropharmacology 93, 28\u201340 (2015).","journal-title":"Neuropharmacology"},{"key":"8405_CR10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1139\/y88-160","volume":"66","author":"M Quik","year":"1988","unstructured":"Quik, M. & Geertsen, S. Neuronal nicotinic \u03b1-bungarotoxin sites. Can. J. Physiol. Pharmacol. 66, 971\u2013979 (1988).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"8405_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0896-6273(01)00461-5","volume":"32","author":"M Harel","year":"2001","unstructured":"Harel, M. et al. The binding site of acetylcholine receptor as visualized in the X-ray structure of a complex between \u03b1-bungarotoxin and a mimotope peptide. Neuron 32, 265\u2013275 (2001).","journal-title":"Neuron"},{"key":"8405_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1476-5381.2009.00532.x","volume":"159","author":"L Quinton","year":"2010","unstructured":"Quinton, L. et al. Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptor. Br. J. Pharmacol. 159, 316\u2013325 (2010).","journal-title":"Br. J. Pharmacol."},{"key":"8405_CR13","doi-asserted-by":"publisher","first-page":"e68841","DOI":"10.1371\/journal.pone.0068841","volume":"8","author":"A Ma\u00efga","year":"2013","unstructured":"Ma\u00efga, A. et al. Orthosteric binding of \u03c1-Da1a, a natural peptide of snake venom interacting selectively with the \u03b11A-adrenoceptor. PLoS ONE 8, e68841 (2013).","journal-title":"PLoS ONE"},{"key":"8405_CR14","unstructured":"Endo, T., Tamiya, N. & Harvey, A. Snake toxins. 165\u2013222 (Pergamon Press, New-York, 1991)."},{"key":"8405_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1472-8206.2009.00805.x","volume":"24","author":"B Haenisch","year":"2010","unstructured":"Haenisch, B. et al. Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam. Clin. Pharmacol. 24, 729\u2013739 (2010).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"8405_CR16","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/01.ju.0000097026.43866.cc","volume":"171","author":"CG Roehrborn","year":"2004","unstructured":"Roehrborn, C. G. & Schwinn, D. A. \u03b11-Adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.  J. Urol. 171, 1029\u20131035 (2004).","journal-title":"J. Urol."},{"key":"8405_CR17","doi-asserted-by":"crossref","unstructured":"Rossi, M. & Roumegu\u00e8re, T. Silodosin in the treatment of benign prostatic hyperplasia. Drug Des. Dev. Ther. 4, 291\u2013297 (2010).","DOI":"10.2147\/DDDT.S10428"},{"key":"8405_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0022-5347(01)67240-9","volume":"154","author":"A Fawzy","year":"1995","unstructured":"Fawzy, A. et al. Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study.  J. Urol. 154, 105\u2013109 (1995).","journal-title":"J. Urol."},{"key":"8405_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2165\/00003495-199549020-00011","volume":"49","author":"B Fulton","year":"1995","unstructured":"Fulton, B., Wagstaff, A. J. & Sorkin, E. M. Doxazosin. Drugs 49, 295\u2013320 (1995).","journal-title":"Drugs"},{"key":"8405_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/01.pra.0000452561.98286.1e","volume":"20","author":"B Green","year":"2014","unstructured":"Green, B. Prazosin in the treatment of PTSD. J. Psychiatr. Pract. 20, 253\u2013259 (2014).","journal-title":"J. Psychiatr. Pract."},{"key":"8405_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39310-x","volume":"14","author":"Y Toyoda","year":"2023","unstructured":"Toyoda, Y. et al. Structural basis of \u03b11A-adrenergic receptor activation and recognition by an extracellular nanobody. Nat. Commun. 14, 3655 (2023).","journal-title":"Nat. Commun."},{"key":"8405_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1126\/science.aax2517","volume":"369","author":"S Maeda","year":"2020","unstructured":"Maeda, S. et al. Structure and selectivity engineering of the M muscarinic receptor toxin complex. Science 369, 161\u2013167 (2020).","journal-title":"Science"},{"key":"8405_CR23","doi-asserted-by":"publisher","first-page":"e0175642","DOI":"10.1371\/journal.pone.0175642","volume":"12","author":"R Nehm\u00e9","year":"2017","unstructured":"Nehm\u00e9, R. et al. Mini-G proteins: Novel tools for studying GPCRs in their active conformation. PLoS ONE 12, e0175642 (2017).","journal-title":"PLoS ONE"},{"key":"8405_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-14889-7","volume":"11","author":"T Che","year":"2020","unstructured":"Che, T. et al. Nanobody-enabled monitoring of kappa opioid receptor states. Nat. Commun. 11, 1\u201312 (2020).","journal-title":"Nat. Commun."},{"key":"8405_CR25","doi-asserted-by":"publisher","unstructured":"Robertson, M. J. et al. Structure determination of inactive-state GPCRs with a universal nanobody. Nat. Struct. Mol. Biol. https:\/\/doi.org\/10.1038\/s41594-022-00859-8 (2022).","DOI":"10.1038\/s41594-022-00859-8"},{"key":"8405_CR26","doi-asserted-by":"crossref","unstructured":"Ballesteros, J. A. & Weinstein, H. in Methods in Neurosciences Vol. 25 366\u2013428 (Elsevier, 1995).","DOI":"10.1016\/S1043-9471(05)80049-7"},{"key":"8405_CR27","doi-asserted-by":"publisher","first-page":"811365","DOI":"10.3389\/fmolb.2022.811365","volume":"9","author":"A-C Van Baelen","year":"2022","unstructured":"Van Baelen, A.-C. et al. Structural and functional diversity of animal toxins interacting with GPCRs. Front. Mol. Biosci. 9, 811365 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"8405_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev.pharmtox.42.091101.144224","volume":"42","author":"L Shi","year":"2002","unstructured":"Shi, L. & Javitch, J. A. The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. Annu. Rev. Pharmacol. Toxicol. 42, 437 (2002).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"8405_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/prot.20768","volume":"62","author":"JS Surgand","year":"2006","unstructured":"Surgand, J. S., Rodrigo, J., Kellenberger, E. & Rognan, D. A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins Struct. Funct. Bioinform. 62, 509\u2013538 (2006).","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"8405_CR30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41422-020-00424-2","volume":"31","author":"X Xu","year":"2021","unstructured":"Xu, X. et al. Binding pathway determines norepinephrine selectivity for the human \u03b21AR over \u03b22AR. Cell Res. 31, 569\u2013579 (2021).","journal-title":"Cell Res."},{"key":"8405_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature12572","volume":"502","author":"AM Ring","year":"2013","unstructured":"Ring, A. M. et al. Adrenaline-activated structure of \u03b22-adrenoceptor stabilized by an engineered nanobody. Nature 502, 575\u2013579 (2013).","journal-title":"Nature"},{"key":"8405_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41586-021-03376-8","volume":"592","author":"P Xu","year":"2021","unstructured":"Xu, P. et al. Structural insights into the lipid and ligand regulation of serotonin receptors. Nature 592, 469\u2013473 (2021).","journal-title":"Nature"},{"key":"8405_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cell.2021.01.028","volume":"184","author":"P Xiao","year":"2021","unstructured":"Xiao, P. et al. Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes. Cell 184, 943\u2013956.e918 (2021).","journal-title":"Cell"},{"key":"8405_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-20221-0","volume":"11","author":"D Im","year":"2020","unstructured":"Im, D. et al. Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone. Nat. Commun. 11, 1\u201311 (2020).","journal-title":"Nat. Commun."},{"key":"8405_CR35","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1021\/acs.jpcb.7b02997","volume":"121","author":"S Yasuda","year":"2017","unstructured":"Yasuda, S. et al. Hot-spot residues to be mutated common in G protein-coupled receptors of class A: identification of thermostabilizing mutations followed by determination of three-dimensional structures for two example receptors.  J. Phys. Chem. B 121, 6341\u20136350 (2017).","journal-title":"J. Phys. Chem. B"},{"key":"8405_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jsb.2005.01.002","volume":"150","author":"J Lei","year":"2005","unstructured":"Lei, J. & Frank, J. Automated acquisition of cryo-electron micrographs for single particle reconstruction on an FEI Tecnai electron microscope. J. Struct. Biol. 150, 69\u201380 (2005).","journal-title":"J. Struct. Biol."},{"key":"8405_CR37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"8405_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"8405_CR39","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J. Comput Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput Chem."},{"key":"8405_CR40","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. D Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"8405_CR41","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D: Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"8405_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"8405_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12735","volume":"504","author":"AC Kruse","year":"2013","unstructured":"Kruse, A. C. et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature 504, 101\u2013106 (2013).","journal-title":"Nature"},{"key":"8405_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1124\/mol.61.1.65","volume":"61","author":"G Swaminath","year":"2002","unstructured":"Swaminath, G., Steenhuis, J., Kobilka, B. & Lee, T. Allosteric modulation of beta2-adrenergic receptor by Zn(2+). Mol. Pharmacol. 61, 65\u201372 (2002).","journal-title":"Mol. Pharmacol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08405-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:22:50Z","timestamp":1757247770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08405-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8405"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08405-0","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"2 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1055"}}